Download PDF
1 / Pages

Other users also viewed these articles

Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients Marcela Valverde-Monge; Patricia Sánchez-Carrasco; Diana Betancor; Blanca Barroso; José Manuel Rodrigo-Muñoz; Ignacio Mahillo-Fernández; Ebymar Arismendi; Irina Bobolea; Blanca Cárdaba; María Jesús Cruz; Victoria Del Pozo; Javier Domínguez-Ortega; Francisco Javier González-Barcala; José María Olaguibel; Juan Alberto Luna-Porta; Carlos Martínez-Rivera; Joaquim Mullol; Xavier Muñoz; Lorena Peleteiro-Pedraza; Cesar Picado Valles; Vicente Plaza; Santiago Quirce; Manuel Jorge Rial; Lorena Soto-Retes; Antonio Valero; Joaquín Sastre;
Arch Bronconeumol. 2024;60:23-32
Pathological N1/N2 in Clinical Stage I Bronchogenic Carcinoma. Analysis From a Prospective Multicentre Database Alejandra Romero Román; Silvana Crowley Carrasco; Mariana Gil Barturen; Ana Royuela; Carme Obiols; Sergi Call; José Luis Recuero; Íñigo Royo; Raúl Embún; David Gómez de Antonio;
Arch Bronconeumol. 2023;59:364-9
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry Alberto García Ortega; David Jiménez; Ana Pedro-Tudela; Cristina Pérez-Ductor; Carmen Fernández-Capitán; Conxita Falgá; Andris Skride; Carmine Siniscalchi; Ido Weinberg; Manuel Monreal;
Arch Bronconeumol. 2024;60:143-52